NPHCDA Immunization FHIR IG
0.7.0 - ci-build Nigeria flag

NPHCDA Immunization FHIR IG, published by https://nphcda.gov.ng. This guide is not an authorized publication; it is the continuous build for version 0.7.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Nigeria-FHIR-Community/NPHCDA-ImmunizationIG/ and changes regularly. See the Directory of published versions

Example AllergyIntolerance: Example NG-Imm Allergy Intolerance -001

NG-Imm Allergy Dose Number: 165

NG-Imm Dose Series: Pentavalent Infant Series

clinicalStatus: Active

verificationStatus: Confirmed

type: Allergy

category: Medication, Biologic

criticality: High Risk

code: Adverse reaction to immunization

patient: Chinedu Emeka Okafor Male, DoB: 2020-05-15 ( NIN)

encounter: Encounter: extension = ; status = in-progress; class = PHC Center Level 2 (IMMZ.D.DE3 Facility Type CS#phc-center-l2)

onset: 2025-08-01 09:30:00+0100

recordedDate: 2025-08-01 10:00:00+0100

recorder: Practitioner Nkiru Okafor

lastOccurrence: 2025-08-01 12:00:00+0100

Reactions

-SubstanceManifestationDescriptionOnsetSeverity
*Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug)Skin rashPatient developed rash and swelling within 30 minutes of immunization.2025-08-01 10:15:00+0100Moderate